The aim of this study is to describe the presence of genes encoding 4 virulence factors (pvl, eta, etb and tsst) and the mecA gene conferring resistance to beta-lactam antibiotics in patients with diabetes and staphylococcal foot infection. We also aimed to analyse whether isolates of S aureus from cases with bone infection (osteomyelitis) have a different profile for these genes compared with those from exclusively soft tissue infection. In addition to investigating the association of these virulence factors with developing osteomyelitis, we sought to determine if there are differences in the outcomes of S aureus infections involving exclusively soft tissue compared with those involving bone. Finally, for cases of osteomyelitis we sought to assess the influence of the isolation of methicillin-resistant S aureus (MRSA), compared methicillin-sensitive S aureus (MSSA), on clinical outcomes.
Methods
This was a cross-sectional exploratory study, based on a prospectively recruited series of patients aged ≥18 years who were admitted to the Diabetic Foot Unit, San Juan de Dios Hospital, San José, Costa Rica for a moderate or severe DFI from June 1, 2014 to May 31, 2016. We excluded patients who were: pregnant; undergoing haemodialysis for end-stage renal disease; receiving treatment with corticosteroids or other immunosuppressant drugs; diagnosed with a malignancy and were (or had recently) undergone treatment with antineoplastic or radiation therapy; infected with the human immunodeficiency virus; suffering from hepatic insufficiency, severe malnutrition, or a mental disorder that precluded understanding the scope of the study.
We defined the presence and severity of infection according to de Infectious Diseases Society of America (IDSA) criteria. 10 We assessed the patient's demographic factors, types of diabetes treatments, and diabetes-related complications and noted the presence of necrosis or signs of inflammation. We diagnosed limb ischemia when one of the ipsilateral pedal pulses was not palpable or the ankle-brachial index was <0.9. We classified patients as having critical limb ischemia (CLI) based on the TASC II criteria. 11 We diagnosed osteomyelitis with a sequential approach that included a clinical evaluation, the probe-to-bone test and plain radiographs, as previously described. 12 When diagnostic uncertainty remained after these evaluations, we obtained advanced imaging with a radionuclide scan (usually a 3-phase bone scan). We followed up on all patients who appeared to have exclusively soft tissue infection (STI) to ensure they did not shown evidence of osteomyelitis during the clinical course of treatment. We dropped any patient from the study who had presumed osteomyelitis, but a bone specimen did not display typical changes of osteomyelitis on histopathology. 1 For all patients (with either STI or osteomyelitis) we performed wound debridement during the first 48 hours after their admission. We collected samples from infected soft tissue and from bone (in cases of osteomyelitis) in the operating theatre, which were immediately sent for processing to the microbiology and pathology departments. Samples were cultured in blood and mannitol agars. We used the Vitek 2 card (BioMerieux, Marcy-l'Etoile, France) for genus and species identification and antimicrobial susceptibility testing.
After the initial surgical procedure, all patients received empiric systemic antibiotic therapy, following the current local and international guidelines for clinical management. For cases in which the laboratory results revealed monomicrobial S aureus infection, the isolates were sent to the Molecular Diagnostic Laboratory of the National Children's Hospital for the identification of virulence factors and mecA gene encoding resistance to methicillin, as described below. Wound healing was defined as complete epithelialization of the foot wound at two consecutive visits during follow-up.
Polymerase Chain Reaction Techniques
Primers used for polymerase chain reaction (PCR) amplification of the five virulence genes were as follows: mecA gene encoding for methicillin resistance (MecA1 5′AAA ATC GAT GGT AAA GGT TGG C3′, MecA2 5′AGT TCT GCA GTA CCG GAT TTG C3′) 13 ; pvl gene encoding for Panton Valentine leucocidin (PVL1 5′ATC ATT AGG TAA AAT GTC TGG ACA TGA TCC A3′, PVL2 5′GCA TCA AST GTA TTG GAT AGC AAA AGC 3′) 14 ; tsst gene encoding for toxic-shock syndrome toxin (tsst-1 5′TTC ACT ATT TGT AAA AGT GTC AGA CCC ACT 3′, 5′TAC TAA TGA ATT TTT TTA TCG TAA GCC CTT 3′) 14 ; and exfoliative toxins coding for etA and etB genes (etA1 5′ACT GTA GGA GCT AGT GCA TTT GT3′, etA2 5′TGG ATA CTT TTG TCT ATC TTT TTC ATC AAC 3′, etB1 5′CAG ATA AAG AGC TTT ATA CAC ACA TTA C3′; etB2 5′AGT GAA CTT ATC TTT CTA TTG AAA AAC ACT C3′). For statistical testing, we used median and interquartile range (IQR) for nonnormally distributed continuous variables, mean and standard deviation (SD) for normally distributed continuous variables, and percentage for discrete variables. We analyzed discrete variables by the χ 2 test and, where appropriate, the Fisher's exact test, and nonnormally distributed quantitative variables using the nonparametric Mann-Whitney U test. Included patients were divided into 2 groups: amputated (major or minor) and nonamputated. Variables with P < .05 after univariate analysis were subsequently included in a multivariate analysis to identify the independent predictors of amputation by using a stepwise forward logistic regression analysis. The subset of patients with osteomyelitis was separately analyzed to study the effect of isolation of MRSA from wound specimens. We performed Cox's proportional hazards model for time to healing and estimated hazard ratios (HRs). Statistical analysis was performed with SPSS version 20 for MacOS (IBM Corp, Armonk, NY, USA) and P < .05 was set as the threshold of statistical significance.
All the patients gave informed consent to be included in the study. This study was approved by the Ethical Committee of San Juan de Dios Hospital (Caja Costarricense de Seguro Social), San José, Costa Rica (code CLOBI-HSJD-23-2014).
Results
During the study period, we treated 379 patients for a DFI. S aureus was isolated from 101 wound samples, of which 43 were polymicrobial infections; the 58 cases with monomicrobial S aureus infection constituted our study group. The mean age of these 58 patients was 58.2 years (SD = 12.4) and their mean duration of diabetes was 14.8 years (SD = 8.7). Among those with monomicrobial S aureus infection 17 (29.3%) had exclusively soft tissue infections and 41 (70.7%) had osteomyelitis. Infection severity was classified as moderate in 22 cases (37.9%) and severe in 36 (62.1%).
Molecular analysis of the S aureus isolates detected the mecA gene in 35 cases (60.3%), pvl gene in 4 cases (6.9%) and tsst gene in 3 (5.2%). The etA or etB genes were not detected in any case. The pvl gene was found in 3 mecA+ cases (8.6% of mecA+ cases) and in 1 mecA-case (4.3%), P = .4. The 4 cases with pvl encoding genes were all isolated from STI patients, with none found in the osteomyelitis cases (P = .006). The presence of pvl was associated with a history of a shorter duration of the foot ulcer. Table 1 shows the analysis of the patients' demographic characteristics, clinical presentation of the infection, and presence of the virulence factors, grouped by whether they had STI or osteomyelitis. After applying a logistic regression model, the only predictive factor that was associated with the outcome of lower extremity amputation was the presence of necrosis (P = .01, odds ratio [OR] = 6.6, 95% confidence intervals [CI] = 1.5-28.4). Table 2 shows the analysis of the association of the genes studied with several variables of interest, none of which was statistically significant. Table 3 shows the analysis of only the patients with osteomyelitis, to compare cases with MRSA versus those with MSSA. After applying Cox's proportional hazards model for time to healing, osteomyelitis caused by MRSA was associated with longer time to healing (P = .03, HR 62.1, 95% CI = 1.0-4.1).
Discussion
Our analysis of S aureus isolates from patients with a DFI demonstrated a high rate (60.3%) of isolates harboring the mecA gene, that is, MRSA strains. However, there were no significant differences in the rates between cases of STI versus osteomyelitis (P = .18). Previously reported rates of prevalence of the mecA gene in patients with a DFI were 43.5%, 15 38.6%, 16 36%, 9 and 60.5%. 8 An analysis of the molecular epidemiology of S aureus strains isolated from inpatients with an infected diabetic foot ulcers in an Algerian hospital reported that 85.9% of the had the mecA gene and these MRSA infections were associated with previous antimicrobial therapy. 17 A study of DFI from India reported that the presence of mecA gene was not associated with the severity of the infection. 8 We found no association between the presence of mecA gen and previous hospitalization (P = 1.0), the severity of the infection (P = .87), presence of necrosis (P = .54), likelihood of undergoing amputation (P = .1), duration of antibiotic treatment (P = .20), or time to healing (P = .11). This is compatible with the findings of other studies that that reported the presence of MRSA was not associated with a poorer prognosis or with treatment failure. [18] [19] [20] In our study, however, among the subset of patients with osteomyelitis those infected by mecA+ strains had a longer time to wound healing.
The pvl encoding gene was detected in just 4 cases (6.9%) in our series, all in patients with STI and none with osteomyelitis (P = .006). Although we found no strains isolated from bone samples with the pvl gene in our study, another study reported that 70% of strains isolated from osteomyelitis (not specifically in diabetic foot patients) displayed a pvl encoding gen. 21 A national French study first described the emergence of the CC398 MSSA clone, the main clone in diabetic foot osteomyelitis, and its tropism for bone. 16 The pvl gene was absent in strains related to diabetic foot osteomyelitis in CC398 clone. 16 Another study from Portugal reported that none of their isolates from diabetic foot ulcers was pvlpositive. 22 Similarly, the pvl gene was not detected among the isolates in a study from Poland, in which MRSA was detected in 10.3% of the isolates. 23 In other studies of infected diabetic foot ulcers, the pvl gene was found in 14.1% of the strains in Algeria 17 and in 57% in India. 8 There was no association between the presence of the pvl gene and the severity of the infection in the India study but strains carrying the pvl gene were found in wound samples from 85% of patients who had undergone an amputation. 8 The presence of the pvl gene was also associated with worse prognosis in the Algeria experience. 17 However, the high rate of lower extremity amputation could be explained by the differences on the management of DFI in that country. In our study, there was no significant relationship between the presence of pvl gene and a history of ulceration (P = .29), amputation (P = .57), or previous hospitalization (P = .56). While cases with pvl gene positive strains had a history of a shorter duration of the ulcer, the significance of this finding is unknown. Thus, the presence of pvl gene was not associated with worse outcomes in our study.
We detected the tsst gene in 3 samples (5.2%) in our study, with no difference in rates between the soft tissue infection and osteomyelitis cases (P = .87). Another study reported this toxin in 8% of samples obtained from neuropathic non-infected diabetic foot ulcers. 9 Other studies reported rates of tsst-1 positive strains in cases of diabetic foot ulcers of 13%, 24 13.9%, 8 and 19%. 25 Of note is that tsst was not detected in patients with grade I (uninfected) foot ulcers. 8 No strains of S aureus were positive to tsst from the studies from Algeria 17 or from Africa. 21 Among our cases we did not detect genes encoding for etA or etB. These virulence factors were also not detected in previously reported cases of DFIs, 17 osteomyelitis (not specific to the diabetic foot), 21 and diabetic foot osteomyelitis. 16 However, a report from Europe noted that 13% and 17% of the strains from DFIs harboured etA and etB, respectively. 24 In a report from France, 3% of S aureus strains from diabetic foot ulcers were etA +, but no strain harbored etB. 25 We also analyzed for differences in these genes between S aureus isolates from soft tissue and bone infections. Osteomyelitis was significantly associated with failure of conservative surgery, compared with soft tissue infections. However, osteomyelitis was not a risk factor for amputation in our logistic regression model. An Italian group reported that patients with soft tissue abscesses had a poorer prognosis than patients with chronic osteomyelitis. 26 However, other To our knowledge, this is the first prospective study that assessed the importance of S aureus associated with DFI in patients of Costa Rica that incorporated molecular analyses to evaluate virulence factors and mecA gene. The main limitation of our study is that we investigated just 4 of the S aureus virulence factors. These were the ones that with which our microbiologist had experience and that we could assess in our laboratory. Thus, we did not test some virulence factors that have been found to be important in other studies of diabetic foot ulcers and nondiabetic foot osteomyelitis. Furthermore, we didn't study the clonal diversity of the S aureus isolates. Another limitation is that our microbiology laboratory did not do anaerobic cultures, so our assumption that the infections were monomicrobial may be incorrect if we missed obligate anaerobes. An additional limitation is the small size of our sample. The strengths of this investigation include the fact that it is a prospective study, all samples for culture were taken by tissue biopsy under aseptic conditions, and every patient classified as having osteomyelitis had a definitive pathological diagnosis.
In conclusion, we found no difference in the profile of S aureus genes encoding for selected virulence factors (pvl, etA, etB, and tsst) that were recovered from DFIs, regardless of whether the infection involved exclusively soft tissue or bone. However, we found that the prevalence of pvl+ S aureus was significantly associated with STI, compared with bone infection. Furthermore, we observed a significantly longer time to wound healing among patients infected with mecA+ S aureus (MRSA). Finally, we found few isolates with genes encoding tsst and none with etA, etB. Future research may elucidate the presence of other virulence factors of S aureus among this important population, as well as determine its role in evolution and therapy. 
